Serum KL-6 as a Biomarker of Progression at Any Time in Fibrotic Interstitial Lung Disease

The development of a progressive phenotype of interstitial lung disease (ILD) is still unpredictable. Whereas tools to predict mortality in ILD exist, scores to predict disease progression are missing. The aim of this study was to investigate whether baseline serum KL-6 as an established marker to a...

Descripción completa

Detalles Bibliográficos
Autores principales: Jehn, Lutz B., Costabel, Ulrich, Boerner, Eda, Wälscher, Julia, Theegarten, Dirk, Taube, Christian, Bonella, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917700/
https://www.ncbi.nlm.nih.gov/pubmed/36769819
http://dx.doi.org/10.3390/jcm12031173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917700/
https://www.ncbi.nlm.nih.gov/pubmed/36769819
http://dx.doi.org/10.3390/jcm12031173

Ejemplares similares